Contact No: +91-8826373757 | +91-8826859373 | 011-25052216
Email: rakesh.its@gmail.com | editor@innovativepublication.com


Print ISSN:-2393-9079

Online ISSN:-2393-9087

CODEN : IJPPTK

Current Issue

Year 2019

Volume: 6 , Issue: 4

Article view: 725

Article download: 185

Indian Journal of Pharmacy and Pharmacology


Solubility Enhancement of Poorly Water Soluble Drug Aceclofenac


Full Text PDF Share on Facebook Share on Twitter


Author Details : Girish C. Soni, PD Chaudhary, PK Sharma

Volume : 3, Issue : 3, Year : 2016

Article Page : 139-145


Suggest article by email


Abstract

Solid dispersion was aim for increasing solubility and bioavailability of poorly aqueous soluble drug aceclofenac (ACE). Solid dispersion of drug aceclofenac (NSAID) was prepared by using different polymers i.e. Polaxomer 188, PVP k30, PEG 6000, in different ratios 1:1, 1:2, 1:3, by different methods of  solid dispersion preparation i.e. Physical method, solvent evaporation method, melt method.
The prepared formulations was characterised by Differential scanning calorimetry (DSC), Scanning electron microscopy (SEM), X-ray diffraction (XRD), In vitro dissolution studies, drug content estimation, saturation solubility. It was concluded that there is change in the crystalline form of drug into amorphous state during formation of solid dispersion.
Polaxomer 188 in ratio 1:3 through melt method, it shows maximum drug release which is 99.04% in 40 minutes. It was concluded that solid dispersion formation of aceclofenac drug by using polaxomer 188 is promising approach in enhancement of its absorption rate increase bioavailability and minimising its side effects.

Keywords:
Non Steroidal Anti Inflammatory Drugs, Solid dispersion, Aceclofenac, Polaxomer 188

How to cite : Soni G C, Chaudhary P, Sharma P, Solubility Enhancement of Poorly Water Soluble Drug Aceclofenac. Indian J Pharm Pharmacol 2016;3(3):139-145

Copyright © 2016 by author(s) and Indian J Pharm Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)